Censinet Leadership Team

Mr. Winder co-leads the investment activities of the MemorialCare Innovation Fund. He has over 30 years of venture capital investment experience in early to mid-stage healthcare technology companies. He sources, leads, and syndicates deals, and subsequently, he works closely with portfolio companies to develop scalable commercial and marketing strategies to maximize value for founders and shareholders.

Mr. Winder has both private and public company board experience and is currently (or formerly) Board Director or Observer at Aileron Therapeutics (IPO), AristaMD, Aventura (acquired by Philips Medical), Ayogo Health, BabyScripts, ClearDATA, Censinet, Cleveland HeartLab (acquired by Quest Diagnostics), Foldax, InfoBionic, Laudio, Molecular Templates (IPO), Oculus Health, Protenus, ShapeUp (merged with Virgin Pulse, acquired by Marlin), Silvercloud Health (acquired by Amwell), Saladax Biomedical, Twistle (acquired by Health Catalyst), MedVentive (acquired by McKesson), Qstream, WellDoc, and Xcellerex (acquired by GE Healthcare). He also serves as a Trustee for the Ammonoosuc Conservation Trust.

Prior to joining MCIF, Mr. Winder was Co-Founder (and remains) Managing Director at Excel Venture Management. Prior to Excel Venture, Mr. Winder was a Principal at Biotechonomy Ventures where he was involved in the founding of Synthetic Genomics, the firm’s investments in BioTrove (acquired by Life Technologies), BIOCIUS (acquired by Agilent Technologies), and Xcellerex (acquired by GE Healthcare).

Prior to becoming a venture capitalist, Mr. Winder was an award-winning sales and marketing executive at medical equipment and diagnostics companies, Midmark Corporation and MGC Diagnostics. He graduated magna cum laude with an MBA from Olin Graduate School of Business at Babson College, where he was a Fellow in the Center for Technology Enterprise. He earned a BA in Biology and a minor in Economics from Colby College.